Shares of Namaste Technologies (TSXV:N) dipped on Tuesday after the company confirmed a strategy to enter the Canadian adult-use cannabis market.

On Tuesday (August 28) Namaste informed its shareholders the company would enter the recreational cannabis market after previously holding off on its decision to do so.

The company cited “uncertainty” around the federal and provincial adult-use cannabis plans as its reason for staying outside the margins in terms of preparation for this new market, with legalization set to begin in Canada on October 17.

Sean Dollinger, CEO of Namaste, said in the press release the company waited to see how the legislation would pan out in Canada for the sales of recreational cannabis.

“Although we are not a cultivator, we do see significant market share for the company in providing highly valuable technology platforms to the recreational market,” he said.

Namaste’s main business is the service of its NamasteMD portal for medical cannabis patients. Through this service, and its mobile apps, the company can sign up patients seeking medical license for consumption and sell them LP product directly.

In March, Dollinger told the Investing News Network (INN) his estimation for the number of patients enrolled in the NamasteMD service would be 5,500 by the end of 2018.

The executive also revealed the company will be using its partnerships with Canadian licensed producers (LPs) to create a new brand for the company.

Namaste has gotten its hands on cannabis product this year through various supply agreements with other LPs like GTEC Holdings (TSXV:GTEC), Bonify and Tetra Natural Health, a division of Tetra Bio-Pharma (TSXV:TBP).

The company confirmed it will develop a new “private-label line” of cannabis with premium product into the medical and the adult-market. Using the supply agreements, the company is now waiting for the approval of the sales license for its subsidiary Cannmart.

Namaste wants to seek online recreational cannabis sales as provinces open their legal markets. The company expects to use its same day delivery service initially in Toronto and other major Canadian cities.

Investor takeaway

Share price for Namaste dropped following the decision by the company to pursue an entry into the recreational cannabis market in Canada. After the markets closed on Tuesday the company’s stock was priced at C$1.79 per share, a 4.79 percent decrease from its previous closing price.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: GTEC Holdings is a client of the Investing News Network. This article is not paid-for content.

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less